Skip to content

Clinical trials

Completed Phase 2 Immunologic Deficiency Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunologic Deficiency Syndromes Phase: Phase 2 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20042
20051
20062
20081
20092
20112
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Philadelphia3
National Institute of Allergy and Infectious Diseases (NIAID)3
National Cancer Institute (NCI)2
Fondazione Telethon1
Fred Hutchinson Cancer Center1
Grifols Therapeutics LLC1
Indonesia University1
Janssen-Cilag S.p.A.1
Masonic Cancer Center, University of Minnesota1
New York Medical College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunologic Deficiency Syndromes17
Bone Marrow Failure Disorders2
Graft vs Host Disease2
Infections2
Leukocyte-Adhesion Deficiency Syndrome2
Lymphoproliferative Disorders2
Acquired Immunodeficiency Syndrome1
Anemia, Refractory, with Excess of Blasts1
Anemia, Sickle Cell1
COVID-191

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.